Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2020000024) ANTIBACTERIAL TREATMENT USING CANNABINOID COMBINATIONS
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2020/000024 International Application No.: PCT/AU2019/050626
Publication Date: 02.01.2020 International Filing Date: 18.06.2019
IPC:
A61K 31/05 (2006.01) ,A61K 47/14 (2017.01) ,A61P 31/04 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
045
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05
Phenols
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
06
Organic compounds
08
containing oxygen
14
Esters of carboxylic acids
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04
Antibacterial agents
Applicants:
BOTANIX PHARMACEUTICALS LTD [AU/AU]; 63 Aberdeen Street Northbridge, Western Australia 6003, AU
Inventors:
CALLAHAN, Matthew; US
THURN, Michael; US
Agent:
WRAYS PTY LTD; Level 7 863 Hay Street Perth, 6000, AU
Priority Data:
201890233128.06.2018AU
62/691,44128.06.2018US
Title (EN) ANTIBACTERIAL TREATMENT USING CANNABINOID COMBINATIONS
(FR) TRAITEMENT ANTIBACTÉRIEN UTILISANT DES COMBINAISONS DE CANNABINOÏDES
Abstract:
(EN) Compositions and methods for the treatment or prevention of an infection by a bacterium comprising a cannabinoid, or a cannabinoid in combination with a chelating agent, most preferably EDTA. Preferably the infection is a skin infection, and the bacterium is a gram-positive bacteria and/or film-forming bacteria and/or resistant to at least one antibiotic. Preferably the Q cannabinoid is selected from cannabidiol, cannabiol, cannabigerol, cannabichromene and A9-tetrahydrocannabinol, most preferably cannabidiol.
(FR) L'invention concerne des compositions et des procédés pour le traitement ou la prévention d'une infection par une bactérie comprenant un cannabinoïde, ou un cannabinoïde en combinaison avec un agent chélatant, de préférence de l'EDTA. De préférence, l'infection est une infection cutanée, et la bactérie est une bactérie gram-positive et/ou une bactérie filmogène et/ou résistante à au moins un antibiotique. De préférence, le cannabinoïde Q est choisi parmi le cannabidiol, le cannabiol, le cannabigérol, le méichromène et le Δ9-tétrahydrocannabinol, de préférence le cannabidiol.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)